COVID-19 test
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
Cue said it made the decision due to larger economic challenges and the federal government's recent move to divert funding from COVID-19 tests.
Also, an Indian online medical news portal launches a mobile app version.
Also, British medtech company Smith+Nephew launches its robotics platform in India.
The company claims that the testing solution checks the spectral signature of a virus from a nasal or mouthwash sample to detect COVID-19 within seconds.
The test was developed as an alternative to RT-PCR tests, which require trained laboratory technicians to perform and can take days to get results back.
The agency will allow some COVID-19 tests to be used at home for regular asymptomatic testing.
The Ellume COVID-19 Home Test was the first rapid self-test authorized by the FDA for the detection of COVID-19 in individuals with or without symptoms.
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.